Background parenchymal enhancement and uptake as breast cancer imaging biomarkers: A state-of-the-art review

Author(s):  
Ethan Bauer ◽  
Miri Sklair Levy ◽  
Liran Domachevsky ◽  
Debbie Anaby ◽  
Noam Nissan
2013 ◽  
Author(s):  
Nicholas J. Kenney ◽  
Drew Weisenberger ◽  
Richard Brittan ◽  
Benjamin Welch

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Na Hu ◽  
Jinghao Zhao ◽  
Yong Li ◽  
Quanshui Fu ◽  
Linwei Zhao ◽  
...  

Abstract Background The background parenchymal enhancement at breast magnetic resonance imaging use to predict breast cancer attracts many searchers to draw a possible relationship. However, the results of their relationships were conflicting. This meta-analysis was performed to assess breast cancer frequency associations with background parenchymal enhancement. Methods A systematic literature search up to January 2020 was performed to detect studies recording associations between breast cancer frequency and background parenchymal enhancement. We found thirteen studies including 13,788 women at the start with 4046 breast cancer. We calculated the odds ratio (OR) and the 95% confidence intervals (CIs) between breast cancer frequency and background parenchymal enhancement by the dichotomous technique with a random or fixed-effect model. Results Women with minimal or mild background parenchymal enhancement at breast magnetic resonance imaging did not have any risk of breast cancer compared to control women (OR, 1.20; 95% CI 0.54–2.67). However, high background parenchymal enhancement at breast magnetic resonance imaging (OR, 2.66; 95% CI 1.36–5.19) and moderate (OR, 2.51; 95% CI 1.49–4.21) was associated with a significantly higher rate of breast cancer frequency compared to control women. Conclusions Our meta-analysis showed that the women with high and moderate background parenchymal enhancement at breast magnetic resonance imaging have higher risks, up to 2.66 fold, of breast cancer. We suggest that women with high or moderate background parenchymal enhancement at breast magnetic resonance imaging to be scheduled for more frequent follow-up and screening for breast cancer to avoid any complications.


Author(s):  
Halil Kömek ◽  
Canan Can ◽  
Yunus Güzel ◽  
Zeynep Oruç ◽  
Cihan Gündoğan ◽  
...  

2020 ◽  
Vol 15 (1) ◽  
Author(s):  
Zhenhui Nie ◽  
Ningbin Luo ◽  
Junjie Liu ◽  
Xinyi Zeng ◽  
Yu Zhang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document